A variety of studies have stressed the importance of the control of inflamm
atory cell longevity and the balance of pro-survival and pro-apoptotic sign
alling. Recently, asthma was found to be associated with reduced apoptosis
of inflammatory cells in lung tissue. The aim of the study was to investiga
te the systemic activation of apoptosis pathways using cDNA array technolog
y in atopy and asthma. Eighteen atopic asthmatics (AA), eight atopic non-as
thmatic (AN) and 14 healthy control subjects (C) were included in the study
. Peripheral blood mononuclear cells were separated with gradient centrifug
ation, mRNA purified and the reverse-transcribed probes hybridized to cDNA
arrays. The signals were compared by standardizing to the 100 most expresse
d genes and group differences assessed with the Mann-Whitney U-test. We fou
nd a concerted up-regulation of several pro-survival cytokines and growth f
actors in AN and AA. FAS and FASL were not differentially expressed, but FA
ST kinase was over-expressed in AN and AA. The tumour necrosis factor pathw
ay was activated in AN and AA with increased cytokine and receptor levels a
nd increased TRAF2, an intracellular signalling product. There were indicat
ions of a down-regulated p53 system. In contrast, the Bcl-2 family of genes
showed a net pro-apoptotic profile in AN and AA. The group of caspases sho
wed a constant gene expression pattern in all groups. In conclusion, signif
icant differences in the expression of apoptosis-related genes were found i
n peripheral blood of atopic individuals with and without asthma. cDNA arra
y technology proved to be useful and may be complementary to DNA-based stud
ies in order to analyse interactive and multidimensional pathways as shown
here for apoptosis.